Canopy Growth Corp represents values of innovation, integrity, and sustainability. With a corporate philosophy centered on advancing the global cannabis industry, the company strives to drive positive change through responsible cultivation, research, and development. Canopy Growth Corp embraces a commitment to producing high-quality, diverse cannabis products that meet the evolving needs of consumers worldwide. With a focus on transparency and compliance, the company fosters a culture of accountability and ethical practices. By prioritizing sustainability and social responsibility, Canopy Growth Corp aims to create lasting value for its stakeholders and contribute to the growth and acceptance of the cannabis sector.

Canopy Growth Corp is primarily present in several countries and regions around the world. The company has established a significant presence in Canada, where it is headquartered and operates numerous production facilities and retail locations. Additionally, Canopy Growth Corp has expanded its operations to include the United States, with a focus on the growing legal cannabis market. The company has also established a presence in Europe, particularly in Germany and the United Kingdom, where it has acquired various licenses and formed partnerships to distribute and market its products.

Canopy Growth Corp has achieved several significant milestones in its corporate history. One notable milestone was becoming the first cannabis company to be listed on the New York Stock Exchange and the Toronto Stock Exchange in 2018. The company has also established itself as a global leader in the cannabis industry, expanding its operations in multiple countries and entering strategic partnerships with well-known brands like Constellation Brands. Additionally, Canopy Growth Corp has made substantial investments in research and development, leading to innovation in cannabis cultivation and product development. These milestones have solidified Canopy Growth Corp's position as a prominent player in the evolving cannabis market.

Canopy Growth Corp, a prominent Canadian cannabis company, has a rich history and background. Established in 2013, Canopy Growth quickly emerged as a frontrunner in the cannabis industry. The company's founder, Bruce Linton, played a pivotal role in its development. Canopy Growth became the first cannabis producer to be listed on the Toronto Stock Exchange in 2014. With headquarters in Smiths Falls, Ontario, the company focuses on cultivating, producing, and distributing high-quality cannabis products for both medical and recreational use. Canopy Growth has gained global recognition and expanded its operations to various countries, making it one of the most influential players in the cannabis market.

Some of the main competitors of Canopy Growth Corp in the market include Aurora Cannabis, Cronos Group, and Tilray.

Canopy Growth Corp is primarily active in the cannabis industry.

Canopy Growth Corp operates in the cannabis industry and is focused on producing, cultivating, and selling cannabis and hemp products. The company's business model revolves around being a vertically integrated cannabis company, encompassing cultivation, processing, branding, and retailing. Canopy Growth Corp aims to capitalize on the growing demand for cannabis products and aims to provide a diverse range of high-quality cannabis products to both medical and recreational markets globally. With their extensive portfolio of brands and partnerships, Canopy Growth Corp strives to establish itself as a dominant player in the rapidly expanding cannabis market.

Canopy Growth의 P/E 비율은 -0.68입니다.

Canopy Growth의 P/S 비율은 1.51입니다.

Canopy Growth에 대한 AlleAktien 품질 점수는 3/10입니다.

Canopy Growth 매출은 297.15 백만 CAD입니다.

Canopy Growth 이익은 -657.27 백만 CAD입니다.

The Canadian company Canopy Growth Corp was founded in 2013 and has become a leading company in the production and marketing of medical cannabis and recreational marijuana. The business model consists of various divisions that focus on the production, sale, and research of cannabis. Production: Canopy Growth Corp owns several production facilities in Canada where they cultivate and harvest various marijuana strains. The production facilities are equipped with state-of-the-art equipment and technologies to ensure the highest quality of cannabis. The company also has partnerships with other companies to ensure the worldwide delivery of cannabis. Sale: Canopy Growth Corp has developed its own brand of medical cannabis called Spectrum Therapeutics, which is available in Canada and other countries. The products range from dried flowers to oils and capsules. Additionally, the company has also developed a brand called Tweed, which focuses on the recreational market. Tweed offers various marijuana strains in different forms such as vapes, edible cannabis, and dried flowers. Research: Canopy Growth Corp has a research and development department that focuses on the development of new cannabis products. The company works closely with other scientists and researchers to study the effects of cannabis on various health conditions. They also have a partner program called Canopy Rivers, which allows other companies to invest in the cannabis industry. It is important to emphasize that Canopy Growth Corp has a close partnership with the alcoholic beverage manufacturer Constellation Brands. Constellation Brands invested about $4 billion in Canopy Growth Corp in 2018. The two companies work together to introduce new products to the market that contain both alcoholic beverages and cannabis. Canopy Growth Corp is a major player in the global market for medical cannabis and recreational marijuana. The company has a clear vision to study the effects of cannabis on various health conditions and develop new products. The partnership with Constellation Brands also shows the interest of major companies in the cannabis industry. In Germany, Canopy Growth Corp has a subsidiary called Spektrum Cannabis GmbH, which distributes medical cannabis in the German market. The products are only available by prescription and are delivered by various pharmacies in Germany. Canopy Growth Corp also advocates for the legalization of medical cannabis in other countries to facilitate access for patients. The company Canopy Growth Corp is a leading company in the production and marketing of medical and recreational marijuana. They have production facilities in Canada and partnerships with other companies for worldwide delivery. They have their own brands for medical cannabis (Spectrum Therapeutics) and recreational marijuana (Tweed). They also have a research and development department focusing on developing new cannabis products and work with other scientists and researchers. Canopy Growth Corp has a partnership with Constellation Brands, a major alcoholic beverage manufacturer, to develop products that combine alcohol and cannabis. In Germany, they have a subsidiary called Spektrum Cannabis GmbH that distributes medical cannabis. They are also advocating for the legalization of medical cannabis in other countries.

Canopy Growth은(는) 연간 번의 배당을 통해 0 CAD의 배당금을 지급합니다.

Canopy Growth의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Canopy Growth의 ISIN은 CA1380351009입니다.

Canopy Growth의 WKN은 A140QA입니다.

Canopy Growth의 티커는 WEED.TO입니다.

지난 12개월 동안 Canopy Growth은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Canopy Growth은(는) 0 CAD의 배당금을 지급할 것으로 예상됩니다.

Canopy Growth의 현재 배당 수익률은 입니다.

Canopy Growth은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Canopy Growth은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 CAD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Canopy Growth은 '건강' 섹터에 속합니다.

Canopy Growth의 마지막 배당금을 0 CAD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Canopy Growth는 0 CAD를 배당금으로 지급했습니다.

Canopy Growth의 배당금은 CAD에 지급됩니다.